Jiangsu Lianhuan Pharmaceutical Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 73.7%

Jiangsu Lianhuan Pharmaceutical Co Ltd strategic asset allocation index. Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Strategic Asset Allocation Index of 73.7% as of June 2023. Strategic assets (PP&E of CN¥1.06 Billion plus long-term investments of CN¥-) total CN¥1.06 Billion, measured against net assets of CN¥1.44 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 600513 tangible net worth ratio to evaluate the tangible quality of the company's equity base.

SAAI

73.7%
Strategic Assets / Net Assets

Strategic Assets

CN¥1.06 Billion
PP&E + LT Investments

PP&E

CN¥1.06 Billion
CNY

Net Assets

CN¥1.44 Billion
CNY

Strategic Asset Allocation Index of Jiangsu Lianhuan Pharmaceutical Co Ltd (2000–2022)

Strategic asset allocation index of Jiangsu Lianhuan Pharmaceutical Co Ltd from 2000 to 2022. This chart shows how Jiangsu Lianhuan Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 73.7%, representing strategic assets of CN¥1.06 Billion against net assets of CN¥1.44 Billion CNY.

Jiangsu Lianhuan Pharmaceutical Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Jiangsu Lianhuan Pharmaceutical Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Jiangsu Lianhuan Pharmaceutical Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) total market value.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 71.1% CN¥1.01 Billion CN¥1.01 Billion CN¥- CN¥1.41 Billion ▼ -4.9 pp
2021 76.0% CN¥973.93 Million CN¥973.93 Million CN¥- CN¥1.28 Billion ▲ +15.7 pp
2020 60.4% CN¥713.43 Million CN¥713.43 Million CN¥- CN¥1.18 Billion ▼ -3.3 pp
2019 63.7% CN¥690.44 Million CN¥690.44 Million CN¥- CN¥1.08 Billion ▲ +17.1 pp
2018 46.6% CN¥441.39 Million CN¥435.80 Million CN¥5.59 Million CN¥946.61 Million ▲ +19.6 pp
2017 27.0% CN¥237.51 Million CN¥231.08 Million CN¥6.43 Million CN¥878.23 Million ▲ +2.6 pp
2016 24.5% CN¥202.43 Million CN¥196.59 Million CN¥5.84 Million CN¥827.25 Million ▼ -5.0 pp
2015 29.5% CN¥228.48 Million CN¥186.05 Million CN¥42.43 Million CN¥774.88 Million ▼ -12.9 pp
2014 42.4% CN¥184.14 Million CN¥184.14 Million CN¥- CN¥434.25 Million ▼ -1.3 pp
2013 43.7% CN¥175.55 Million CN¥175.55 Million CN¥- CN¥402.11 Million ▲ +13.5 pp
2012 30.2% CN¥105.68 Million CN¥105.68 Million CN¥- CN¥350.42 Million ▼ -1.9 pp
2011 32.1% CN¥105.03 Million CN¥105.03 Million CN¥- CN¥327.61 Million ▲ +1.3 pp
2010 30.7% CN¥94.92 Million CN¥94.92 Million CN¥- CN¥308.95 Million ▼ -0.7 pp
2009 31.4% CN¥92.40 Million CN¥92.40 Million CN¥- CN¥293.89 Million ▲ +0.4 pp
2008 31.0% CN¥87.38 Million CN¥87.38 Million CN¥- CN¥281.68 Million ▲ +2.8 pp
2007 28.2% CN¥76.25 Million CN¥76.25 Million CN¥- CN¥269.97 Million ▲ +1.2 pp
2006 27.1% CN¥70.19 Million CN¥70.19 Million CN¥- CN¥259.20 Million ▲ +9.6 pp
2005 17.5% CN¥44.85 Million CN¥44.85 Million CN¥- CN¥255.97 Million ▲ +3.2 pp
2004 14.3% CN¥35.78 Million CN¥35.78 Million CN¥- CN¥250.42 Million ▲ +0.5 pp
2003 13.8% CN¥33.97 Million CN¥33.97 Million CN¥- CN¥246.22 Million ▼ -17.3 pp
2002 31.1% CN¥26.50 Million CN¥26.50 Million CN¥- CN¥85.26 Million ▼ -2.1 pp
2001 33.1% CN¥23.02 Million CN¥23.02 Million CN¥- CN¥69.48 Million ▼ -12.7 pp
2000 45.8% CN¥25.29 Million CN¥25.29 Million CN¥- CN¥55.16 Million —
pp = percentage points